Prognosis Analysis of Coronary Heart Disease Complicated with Heart Failure Patients Abandoning PCI and Receiving Drug Comprehensive Therapy
10.6039/j.issn.1001-0408.2016.05.28
- VernacularTitle:放弃PCI术接受药物综合治疗的冠心病合并心力衰竭患者的预后分析
- Author:
Yang ZHANG
;
Xiaoyi ZOU
;
Qiang TAN
;
Qiang SUN
;
Jun ZHAO
;
Jia HAO
;
Shuangjiang LIU
- Publication Type:Journal Article
- Keywords:
Drug comprehensive therapy;
Percutaneous coronary intervention;
Coronary heart disease complicated with heart failure;
Prognosis;
Survival rate
- From:
China Pharmacy
2016;27(5):663-665
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the prognosis of coronary heart disease complicated with heart failure patients abandon-ing percutaneous coronary intervention (PCI) and receiving drug comprehensive therapy. METHODS:From Dec. 2010 to Jul. 2012,217 patients with coronary heart disease complicated with heart failure in our hospital were divided into operation group (105 cases) and non-operation group (112 cases). Based on routine treatment,operation group was given aspirin combined with clopidogrel before and after PCI,and non-operation group was given aspirin combined with clopidogrel all the time. The patients were followed up regularly during discharging from hospital to May 2015 by outpatient,telephone and coronary angiography re-checking,lasting for 24-38 months. Death cases,readmission and revascularization again caused by main adverse cardio-cerebrovas-cular events were recorded during follow-up period. RESULTS:7 cases and 8 cases in operation group and non-operation group did not accept follow-up;median follow-up time was 33 months and 32 months,respectively. Case number of myocardial infarction, heart failure and death in non-operation group was more than operation group,with statistical significance (P<0.05). 94 patients survived in operation group in 3 years,with survival rate of 95.9%;66 in non-operation group,with survival rate of 63.5%;with statistical significance(P<0.05). The survival time of non-operation group was shorter than that of operation group,with statistical significance(P<0.05). CONCLUSIONS:Although we still cannot get the conclusion that PCI is a better treatment or drug therapy is better. But the survival rate of patients are not optimistic 3 years after abandoning PCI coronary heart disease patients with severe myocardial ischemia should choose PCI firstly.
